Role of anastrozole in adjuvant therapy for postmenopausal patients

被引:5
作者
Buzdar, AU [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
关键词
D O I
10.1053/j.seminoncol.2003.08.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:21 / 29
页数:9
相关论文
共 33 条
[1]  
*ASTR ZEN PHARM LP, AR AN TABL PRESCR IN
[2]  
Baum M, 2002, LANCET, V359, P2131
[3]   Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women:: a sub-protocol of the 'Arimidex™ and Tamoxifen Alone or in Combination' (ATAC) trial [J].
Baum, M ;
Dowsett, M ;
Coibion, M ;
Bianco, AR ;
Cuzick, J ;
George, WD ;
Gray, J ;
Howell, A ;
Houghton, J ;
Williams, N ;
Sloane, J ;
Tobias, J ;
Buzdar, A ;
Anderson, MD ;
Jackson, I ;
Sahmoud, T ;
Gallagher, J ;
Webster, A ;
Gangji, D ;
Petrakova, K ;
Konopasek, B ;
Mares, P ;
Vodvarka, P ;
Alcazar, A ;
Campos, O ;
Maxwell, A ;
Goedhals ;
Hacking, D ;
Landers, G ;
Smith, L ;
Vorobiof, DA ;
Werner, ID ;
Blamey, R ;
Coleman, R ;
Grieve, RJ ;
Hickish, T ;
Howell, A ;
Nicholls, JC ;
Nicholson, S ;
Raymond, S ;
Salman, A ;
Blum, J ;
Clark, R ;
Lyss, A ;
Miletello, G ;
Sternberg, J ;
Forbes, J ;
Coibion, M ;
Nabholtz, JM ;
Guastalla, JP .
BRITISH JOURNAL OF CANCER, 2001, 85 (03) :317-324
[4]   Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study [J].
Bonneterre, J ;
Thürlimann, B ;
Robertson, JFR ;
Krzakowski, M ;
Mauriac, L ;
Koralewski, P ;
Vergote, I ;
Webster, A ;
Steinberg, M ;
von Euler, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3748-3757
[5]  
Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO
[6]  
2-Y
[7]  
Brodie AMH, 1996, SEMIN ONCOL, V23, P10
[8]  
Buzdar AU, 1998, CANCER-AM CANCER SOC, V83, P1142, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1142::AID-CNCR13>3.3.CO
[9]  
2-7
[10]  
Camp-Sorrell D, 1997, CANCER PRACT, V5, P391